Strategic Consulting
Building Confidence Through Strategy, Data, and Regulatory Insight
We were particularly impressed with the efficiency and dedication of the MMS team and pleasantly surprised to see deliverables for review ahead of agreed upon deadlines in several instances.
MMS Strategic Consulting brings together regulatory strategy, statistical consulting, and data expertise to support critical decisions across the drug development lifecycle. These consulting services combine regulatory strategy, statistical consulting and data expertise to help Sponsors make confident, evidence-based decisions that reduce risk and improve outcomes.
MMS strategic consultants collaborate across regulatory, clinical, statistical and biometrics functions to ensure that study designs are scientifically sound, operationally feasible and aligned with the expectations of regulators, investors and internal teams. Every engagement is focused on designing thoughtful trials, creating strong development strategies, and building plans that help move programs forward.
MMS supports clients through the following:
- Clinical development and trial design planning
- End-to-end regulatory strategy and submission preparation
- Advanced statistical modeling and risk assessment
- Cross-functional gap analyses and implementation planning
- Global regulatory pathway evaluation and health authority engagement
View our webinar on innovative trial design and regulatory strategy.
MMS statisticians work closely with regulatory experts to ensure that trial designs are ready to answer key questions and stand up to regulatory review. Through platforms like KerusCloud, MMS provides simulation-guided insight to test different trial scenarios, reduce uncertainty and improve planning.
Our depth of support includes:
- Study design evaluation and protocol development
- Estimand strategy and endpoint planning
- Bayesian modeling and complex statistical methods
- Synthetic control arms and RWD integration
- Development plan optimization and investor decision support
Learn how data-focused outsourcing strategies are driving better trial outcomes for sponsors.
MMS provides regulatory guidance starting with early-stage trials through to global marketing applications. The team applies knowledge of precedent and current standards to help Sponsors shape development plans that are clear and aligned with agency expectations. MMS has supported successful submissions to FDA, EMA, MHRA and other global agencies.
Our depth of support includes:
- IND, NDA, BLA and MAA strategy and planning
- Clinical trial application support
- Health authority meeting preparation and representation
- Regulatory gap assessments and roadmap creation
- Strategic content development across modules
Explore insights from our experts on efficiencies for multi-agency submissions.
The same MMS statisticians, regulatory leads and writers who support planning stay engaged through execution. This continuity helps avoid disconnects, keeps messaging consistent and strengthens final submissions.
Sponsors choose MMS because they value responsive service, strong scientific support, and a true partnership approach. The MMS team is focused and ready to help you plan and deliver with confidence.